By Gail Dutton
Cell therapy manufacturers approach autologous therapy manufacturing in multiple ways, with point-of-care manufacturing, academic projects embedded within major medical centers, and centralized manufacturing facilities operated by established biopharmaceutical companies.
Read the article here: Genetic Engineering & Biotechnology News